Cell Signaling Technology (CST): Premium Antibodies & Kits for Cell Signaling Research

Cell Signaling Technology (CST) is a globally recognized, privately held life science company dedicated to providing scientists with the highest-quality antibodies, kits, and reagents for studying cell signaling pathways. Founded in 1999 by active research scientists, CST operates on a straightforward principle: doing the right thing for customers and the planet. With more than 500 employees spanning offices in Danvers, Massachusetts; Beverly, MA; Shanghai; Tokyo; and Leiden (Netherlands), CST has grown into one of the most trusted names in cancer research, immunology, proteomics, and applied systems biology.

Why Cell Signaling Technology Is a Trusted Partner for Scientists

Founded by Scientists, Run by Scientists

Unlike many life science corporations, CST was established in 1999 by working research scientists who understood firsthand the frustrations of using poorly characterized antibodies and unreliable reagents. This heritage is more than a founding story — it continues to define the company today. CST remains privately held and family-owned, insulated from short-term commercial pressures that often compromise product quality in publicly traded companies.

The company’s leadership continues to include active research scientists. Roberto Polakiewicz serves as Chief Scientific Officer, and Matthew Curran as Chief Financial Officer. This scientist-led management structure ensures that product development decisions are driven by genuine laboratory expertise, not purely by market considerations.

Michael Comb, the company’s founder, established a culture of rigorous science at CST. His vision of a “different kind of life science company” — one run by caring people devoted to facilitating good science — continues to shape every product decision, hiring choice, and customer interaction.

Commitment to Scientific Rigor and Reproducibility

Reproducibility is one of the most pressing challenges facing modern biomedical research. CST confronts this challenge directly through its Hallmarks of Antibody Validation philosophy. Recognizing that no single assay is sufficient to validate an antibody, CST validates every product across multiple independent applications before it reaches a researcher’s bench.

This multi-application validation approach means that when a CST antibody is listed as validated for Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Chromatin Immunoprecipitation (ChIP), or Flow Cytometry, researchers can be confident that independent testing — not simply a manufacturer’s assumption — supports that claim.

The same PhD-level scientists who develop CST products are also the ones who provide technical support to customers. This continuity ensures that when a researcher encounters a problem, the support they receive comes from someone with deep, practical knowledge of that specific product.

Global Reach with Local Support

CST’s global operations allow the company to serve researchers across continents while maintaining the quality and service standards of a scientist-founded organization. The company operates dedicated subsidiaries in CST Japan (Tokyo, Chuo-ku), CST China (Shanghai Pudong), and CST Europe (Leiden, Netherlands). Additional operations are maintained at the Cummings Center in Beverly, MA, near the company’s headquarters in Danvers, Massachusetts.

With more than 500–600 employees worldwide, CST maintains a scale that allows for both broad product availability and genuine scientific engagement with customers in their local regions.

Comprehensive Product Portfolio for Every Application

Primary Antibodies — From Phospho-Specific to Recombinant

CST’s antibody catalog is the cornerstone of its product portfolio and the foundation of its global reputation. The company specializes in several critically important antibody types:

• Phospho-Specific Antibodies: CST is recognized as a leading supplier of phospho-specific antibodies — reagents that detect proteins only in their phosphorylated (activated) state. This specificity is essential for studying signal transduction events in real time. CiteAb recognized CST as Phospho Antibody Supplier of the Year, acknowledging the company’s unparalleled depth in this category.
• Recombinant Monoclonal Antibodies: Produced using defined, reproducible genetic sequences, CST’s recombinant monoclonals offer batch-to-batch consistency that polyclonal antibodies cannot match. Researchers can trust that experiments conducted years apart will yield comparable results.
• Chimeric Monoclonal Antibodies: CST’s proprietary chimeric monoclonal format combines the benefits of recombinant production with enhanced specificity for challenging targets.
• Trial Sizes (20 μL): Understanding that researchers want to validate an antibody in their specific system before committing to a full-sized product, CST offers 20 μL trial sizes across much of its catalog. This reduces the financial risk of evaluating new products.

All antibodies are validated in an ISO9001 certified facility, providing an additional layer of quality assurance backed by internationally recognized standards.

Kits and Assays for Validated Results

Beyond individual antibodies, CST offers a comprehensive selection of research kits designed to simplify experimental workflows while maintaining the company’s commitment to validated performance:

• ELISA Kits: Quantitative sandwich immunoassays for measuring protein levels in cell lysates, conditioned media, and biological fluids. Each kit is developed and validated using CST’s own antibodies.
• ChIP Kits: Complete chromatin immunoprecipitation kits designed to simplify one of the most technically demanding protocols in epigenetics research. CST’s ChIP kits include validated antibodies against histone modifications and key transcription factors.
• Proteomics Kits: Sample preparation and enrichment kits that integrate seamlessly with mass spectrometry workflows for studying post-translational modifications (PTMs) at proteome-wide scale.
• Immunoassay Kits: Ready-to-use multiplex and singleplex immunoassay formats for quantitative protein measurement across a wide range of research applications.

Advanced Solutions for Spatial Biology and Single-Cell Analysis

As the life science field moves toward increasingly resolved spatial and single-cell analysis, CST has developed cutting-edge product lines to support these emerging workflows:

• SignalStar® Multiplex IHC: CST’s SignalStar platform enables researchers to simultaneously detect multiple protein targets within a single tissue section using multiplexed immunohistochemistry. This technology preserves spatial context while dramatically increasing information density compared to conventional IHC.
• Cell DIVE Spatial Profiling: Cell DIVE technology extends multiplex capability to high-plex spatial profiling, allowing researchers to map dozens of protein markers across tissue architecture. This platform is particularly powerful for tumor microenvironment studies and immuno-oncology research.
• InTraSeq™ (Single-Cell Analysis): CST’s InTraSeq technology combines antibody-based protein detection with transcriptomic readouts at the single-cell level, enabling joint analysis of proteomic and genomic states within individual cells.

Compatible Workflows and Platforms

CST’s advanced solutions are designed as low-to-high-plex platforms that scale with the researcher’s experimental needs. Whether beginning with simple singleplex IHC and expanding toward full spatial profiling, CST products offer compatibility with a wide variety of instruments, sample types, and downstream analysis platforms. This flexibility makes CST a practical partner across diverse research environments, from academic labs to translational research centers.

Supported Research Applications — Protocols and Tips

Western Blotting (WB)

Western blotting remains the workhorse of protein detection in cell biology, and CST antibodies are among the most highly cited reagents for this application. CST provides:

• Optimized primary antibodies with recommended dilution ranges validated specifically for WB.
• Detailed protocol guidance covering lysis buffer selection, SDS-PAGE conditions, transfer parameters, and blocking strategies.
• Troubleshooting resources through the #CSTTechTips YouTube series, which covers common issues including high background, weak signal, and non-specific bands.
• On-site technical support from PhD-level scientists who can help get experiments back on track when standard troubleshooting steps are insufficient.

Because CST validates antibodies across multiple independent lots before release, researchers consistently find that CST Western Blot antibodies deliver clean, specific bands with minimal non-specific background — even in challenging sample types.

Immunohistochemistry (IHC) and Immunofluorescence (IF)

CST antibodies validated for IHC and IF are tested on formalin-fixed paraffin-embedded (FFPE) tissue sections and frozen tissue, two of the most common sample preparation formats in pathology and translational research. The SignalStar® multiplex IHC platform extends these applications into the spatial biology domain.

CST regularly presents at major scientific conferences, including the American Association for Cancer Research (AACR) Annual Meeting, where researchers can engage with CST scientists about cutting-edge multiplex IHC applications and see poster presentations of the latest data generated using SignalStar and Cell DIVE platforms.

Chromatin Immunoprecipitation (ChIP) and Flow Cytometry

CST maintains one of the most comprehensive validated catalogs of antibodies for chromatin immunoprecipitation. ChIP-validated antibodies from CST have been used in thousands of peer-reviewed publications studying transcription factor binding, histone modifications, and chromatin remodeling across a wide range of cell types and organisms.

For flow cytometry applications, CST antibodies are validated in both intracellular and extracellular formats, supporting immunophenotyping, cell cycle analysis, apoptosis detection, and signaling pathway studies in live and fixed cells.

Proteomics and Post-Translational Modification Analysis

Post-translational modifications (PTMs) — including phosphorylation, acetylation, methylation, ubiquitylation, and glycosylation — are central to virtually every aspect of cell signaling biology. CST’s PhosphoScan® profiling service enables researchers to quantify hundreds of phosphorylation sites simultaneously using antibody-based enrichment followed by mass spectrometry analysis.

This proteomics capability is supported by PhosphoSitePlus®, a comprehensive, NIH-funded database of PTM sites in human, mouse, and rat proteins. Developed with support from the NIH’s Big Data to Knowledge (BD2K) initiative, PhosphoSitePlus is freely accessible to the research community and represents one of CST’s most impactful contributions to open science.

Quality Assurance and Industry Recognition

The Hallmarks of Antibody Validation — Explained

CST’s Hallmarks of Antibody Validation framework represents the company’s foundational approach to ensuring that every antibody it sells meets the highest standards of specificity, sensitivity, and reproducibility. The framework is built on a core insight that has transformed how the industry thinks about antibody quality: no single assay is sufficient to validate an antibody.

In practice, this means every CST antibody is tested across a panel of orthogonal validation strategies, which may include:

• Genetic knockdown or knockout: Testing antibody signal disappearance when the target gene is silenced confirms on-target specificity.
• Recombinant protein overexpression: Demonstrating signal increase when target protein is exogenously expressed confirms positive specificity.
• Independent antibody comparison: Cross-validating results against orthogonal antibodies targeting different epitopes of the same protein reduces the risk of shared off-target binding.
• Cross-reactivity testing: Evaluating signal in cell lines or tissues lacking the target protein identifies potential non-specific binding.
• Multiple application validation: Confirming performance across WB, IHC, IF, ChIP, and Flow Cytometry ensures that validation conclusions are not application-specific artifacts.

This rigorous multi-strategy approach is why CST antibodies consistently outperform competitors in independent benchmarking studies and why they are among the most cited reagents in the peer-reviewed literature.

Awards, Certifications, and Workplace Recognition

CST’s commitment to science and culture has earned widespread recognition:

• CiteAb Phospho Antibody Supplier of the Year: CST has been recognized by CiteAb — the antibody search and review platform — as the leading supplier of phospho-specific antibodies, based on citation analysis in peer-reviewed publications.
• Boston Globe Top 100 Places to Work (2009–2013): CST was recognized for five consecutive years as one of the best employers in the Boston metropolitan area, reflecting its scientist-centered culture and commitment to employee well-being.
• ISO9001 Certified Facility: CST’s manufacturing and quality systems are certified to ISO9001, the internationally recognized standard for quality management systems.
• LEED Certified Facilities: CST’s commitment to environmental sustainability is reflected in its LEED-certified laboratory and office spaces, demonstrating that doing right by the planet is as important to the company as doing right by its customers.

Supporting Your Research — Beyond the Product

Technical Support from PhD-Level Scientists

One of CST’s most valued differentiators is the caliber and depth of its technical support. Unlike companies that staff customer service teams with generalists reading from scripts, CST’s technical support is provided by PhD-level scientists — many of whom were involved in developing the very products they support.

This means that when a researcher contacts CST about troubleshooting a Western blot, optimizing a ChIP protocol, or selecting the right multiplex IHC panel, they are connected with someone who has conducted those experiments personally. CST scientists are available to provide on-site support when complex problems require hands-on intervention, an offering that goes far beyond what most life science companies provide.

Educational Resources and Scientific Events

CST invests heavily in researcher education, recognizing that well-informed scientists get better results from CST products — and from their science in general:

• #CSTTechTips YouTube Series: CST’s YouTube channel features an extensive library of protocol videos, troubleshooting guides, and technique explainers covering Western Blotting, IHC, ChIP, and other core applications. These videos are produced by CST scientists and reflect the same level of rigor that goes into CST’s product validation.
• Scientific Conferences: CST scientists regularly present at major meetings including the AACR Annual Meeting, sharing original research data generated with CST tools and providing researchers with opportunities to engage directly with the people behind the products.
• Webinars and Online Events: CST hosts regular webinars on emerging topics in cell signaling biology, spatial profiling, and single-cell analysis, providing researchers with access to cutting-edge scientific thinking.

Free Bioinformatics Resource: PhosphoSitePlus®

PhosphoSitePlus® is a free, publicly accessible online resource developed and maintained by CST for the global research community. The database catalogs post-translational modification sites — including phosphorylation, acetylation, methylation, ubiquitylation, and glycosylation — in human, mouse, and rat proteins, with curated information drawn from thousands of peer-reviewed publications and mass spectrometry datasets.

Developed with support from the NIH’s Big Data to Knowledge (BD2K) initiative, PhosphoSitePlus enables researchers to explore the regulatory biology of any protein of interest, identify known modification sites, and integrate PTM data with signaling pathway maps. The resource is widely used in academic, pharmaceutical, and biotech research settings worldwide.

Access PhosphoSitePlus at: www.phosphosite.org

Purchasing CST Products

Direct Ordering via cellsignal.com

The primary channel for purchasing CST products is the company’s official website at www.cellsignal.com. The site offers a comprehensive product catalog with detailed datasheets, application notes, validation images, and customer reviews. Researchers can search by target protein, application, species reactivity, or product type.

Important Notice: All Cell Signaling Technology products are For Research Use Only. Not for Use in Diagnostic Procedures. CST products have not been approved for clinical or diagnostic applications.

Authorized Distributors by Region

CST products are also available through a network of authorized regional distributors who provide local language support, regional pricing, and expedited shipping:

• Europe: Bioke (Netherlands and broader European market), BioNordika (Norway and Nordic countries)
• Asia-Pacific: CST Japan (Tokyo) and CST China (Shanghai) serve researchers across Japan, China, and the broader Asia-Pacific region.
• Rest of World: A global network of authorized distributors covers additional regions. Current distributor listings are available at www.cellsignal.com.

Purchasing through authorized distributors ensures access to genuine CST products with full technical support and warranty coverage.

Cell Signaling Technology vs. Other Antibody Suppliers

Selecting the right antibody supplier is a critical decision that affects experimental reproducibility, time to results, and ultimately the reliability of published findings. The following comparison highlights how CST differentiates itself from other major suppliers in the life science research market:

Criterion	CST	Abcam	Santa Cruz Biotechnology
Validation Approach	Hallmarks of Antibody Validation — multi-application, multi-strategy validation for every antibody	Application-specific validation; varies by product	Variable; historically criticized for limited validation data
Scientist-Led Support	PhD scientists who developed the product provide direct technical support; on-site assistance available	Technical support team; quality varies	Standard technical support
Phospho-Specific Antibodies	Industry-leading catalog; CiteAb Phospho Antibody Supplier of the Year	Broad catalog; less specialization in phospho	Limited phospho-specific offerings
Recombinant Monoclonals	Extensive catalog of recombinant monoclonals for reproducibility	Strong recombinant portfolio (Recombinant Advantage)	Primarily traditional hybridoma-based
Spatial Biology Tools	SignalStar multiplex IHC, Cell DIVE, InTraSeq single-cell	Limited proprietary spatial platforms	No dedicated spatial biology platform
Free Bioinformatics Resource	PhosphoSitePlus (NIH-funded PTM database, freely accessible)	No equivalent proprietary database	No equivalent proprietary database
Company Structure	Privately held, family-owned; scientist-led; founded 1999	Acquired by Abcam plc (public company)	Private company
Price Point	Premium pricing reflecting validated quality; trial sizes (20 μL) available	Mid-to-premium range	Lower price point; quality variable
Certifications	ISO9001 certified; LEED certified facilities	ISO9001 certified	Standard certifications
Publication Citations	Consistently among the most cited antibody suppliers globally	High citation count across broad catalog	Declining citation presence in recent literature

Key takeaway: For researchers who prioritize reproducibility, rely on phospho-specific detection, or work in emerging areas such as spatial biology and single-cell proteomics, CST’s validated portfolio and scientist-led support represent a clear advantage over alternatives. The premium price point reflects genuine quality investment rather than brand premium alone.

FAQs

About Cell Signaling Technology

Cell Signaling Technology was founded in 1999 by Michael Comb and a team of research scientists who believed the life science industry could do better — for researchers, for science, and for the world. More than two decades later, the company remains privately held, scientist-led, and committed to the same values that drove its founding: rigorous science, genuine technical support, and a deep sense of responsibility to the research community.

With a catalog spanning thousands of validated antibodies and research kits, global operations serving researchers on every continent, and freely accessible resources like PhosphoSitePlus, CST continues to live out its founding mission as a different kind of life science company — one run by caring people devoted to facilitating good science.